Two Sigma Investments
RCEL icon

Two Sigma Investments’s Avita Medical RCEL Stock Holding History

Two Sigma Investments’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,097
Closed -$152K – 3322
2023
Q4 		$152K Sell
11,097
-70,626
-86% -$810K ﹤0.01% 2891
2023
Q3 		$1.19M Sell
81,723
-62,717
-43% -$1.06M ﹤0.01% 1833
2023
Q2 		$2.46M Buy
144,440
+24,579
+21% +$361K 0.01% 1299
2023
Q1 		$1.67M Buy
119,861
+74,625
+165% +$794K ﹤0.01% 1505
2022
Q4 		$299K Buy
45,236
+30,376
+204% +$182K ﹤0.01% 2248
2022
Q3 		$78K Sell
14,860
-43,250
-74% -$267K ﹤0.01% 2264
2022
Q2 		$276K Buy
+58,110
New +$359K ﹤0.01% 2058
2021
Q1 		– Sell
-46,830
Closed -$870K – 4181
2020
Q4 		$870K Buy
+46,830
New +$1.03M ﹤0.01% 2109

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments's RCEL Position: Q1 2024 in Review

Two Sigma Investments sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 11,097 shares — an estimated $152K sold.

Two Sigma Investments first reported a position in RCEL in Q4 2020 and held it in 8 quarters. The position peaked at $2.46M in Q2 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Two Sigma Investments reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 11,097 Avita Medical shares in Q1 2024, an estimated $152K.
  • Two Sigma Investments first reported a position in Avita Medical in Q4 2020 and held it in 8 quarters.
  • Two Sigma Investments's Avita Medical position peaked at $2.46M in Q2 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.